Free Trial

Olink Holding AB (publ) (OLK) Stock Price, News & Analysis

$24.03
+0.01 (+0.04%)
(As of 05/29/2024 ET)
Today's Range
$23.88
$24.08
50-Day Range
$21.87
$24.43
52-Week Range
$14.10
$26.01
Volume
82,347 shs
Average Volume
580,682 shs
Market Capitalization
$2.99 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$26.00

Olink Holding AB (publ) MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
8.2% Upside
$26.00 Price Target
Short Interest
Bearish
2.30% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.70mentions of Olink Holding AB (publ) in the last 14 days
Based on 4 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.19) to $0.02 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.17 out of 5 stars

Medical Sector

925th out of 932 stocks

Analytical Instruments Industry

28th out of 29 stocks

OLK stock logo

About Olink Holding AB (publ) Stock (NASDAQ:OLK)

Olink Holding AB (publ) develops, produces, markets, and sells biotechnological products and services for the academic, government, biopharmaceutical, biotechnology, service provider, and other institutions that focuses on life science research. The company's products include Olink Explore that consist of Explore 372 and Explore 384 for cardiovascular and metabolic, oncology, neurology, and inflammation diseases; Olink Target product line; Olink Flex, a low-plex applications and use-cases; and Olink Focus product line that consists of custom developed solutions for customers that has identified various proteins of interest or a protein signature to focus on. Its products also comprise Olink Signature Q100, a qPCR readout platform; Olink Analysis services comprising study design and consultation, sample preparation and assay execution, and data processing and QC; and data analysis and bioinformatics services. In addition, the company offers Olink normalized protein expression (NPX) data processing software, a purpose-built software that enable users to import data, perform data analysis including visualizations, and statistical modelling; and Olink Insight, a cloud platform for Olink community to accelerate proteomics. It sells its products and services through its own direct sales force in Sweden, the United States, rest of the Americas, rest of Europe, the Middle East, Africa, Japan, and internationally. The company was formerly known as Knilo HoldCo AB and changed its name to Olink Holding AB (publ) in January 2021. Olink Holding AB (publ) was founded in 2004 and is headquartered in Uppsala, Sweden.

OLK Stock Price History

OLK Stock News Headlines

Olink reports first quarter 2024 financial results
Scotiabank Keeps Their Hold Rating on Olink Holding (OLK)
Olink publishes 2023 annual report
Olink Holding AB Sponsored ADR
Olink Holding AB ADR OLK
Olink Holding AB ADR (OLK)
See More Headlines
Receive OLK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Olink Holding AB (publ) and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/13/2024
Today
5/29/2024
Next Earnings (Estimated)
8/14/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Analytical instruments
Sub-Industry
N/A
Current Symbol
NASDAQ:OLK
Fax
N/A
Employees
707
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$26.00
High Stock Price Target
$26.00
Low Stock Price Target
$26.00
Potential Upside/Downside
+8.4%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
4 Analysts

Profitability

Net Income
$-31,600,000.00
Pretax Margin
-24.84%

Debt

Sales & Book Value

Annual Sales
$169.60 million
Book Value
$3.71 per share

Miscellaneous

Free Float
N/A
Market Cap
$2.98 billion
Optionable
Optionable
Beta
0.50
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Key Executives

  • Mr. Jon Heimer (Age 57)
    CEO & Director
    Comp: $889.39k
  • Mr. Carl Raimond (Age 53)
    President
  • Mr. Oskar Hjelm (Age 39)
    Chief Financial Officer
  • Ms. Anna Marsell (Age 46)
    Chief Operating Officer
  • Mr. Jan Medina CFA
    Vice President of Investor Relations & Capital Markets
  • Ms. Linda Ramirez-Eaves Esq. (Age 52)
    General Counsel
  • Andrea Prander
    Corporate Communications Manager
  • Mr. Elias Berglund
    Chief People Officer
  • Mr. Rickard El Tarzi (Age 38)
    Chief Strategy Officer
  • Mr. Bruno Rossi
    Chief Commercial Officer

OLK Stock Analysis - Frequently Asked Questions

Should I buy or sell Olink Holding AB (publ) stock right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Olink Holding AB (publ) in the last twelve months. There are currently 4 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" OLK shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OLK, but not buy additional shares or sell existing shares.
View OLK analyst ratings
or view top-rated stocks.

What is Olink Holding AB (publ)'s stock price target for 2024?

4 equities research analysts have issued 12 month price objectives for Olink Holding AB (publ)'s stock. Their OLK share price targets range from $26.00 to $26.00. On average, they anticipate the company's stock price to reach $26.00 in the next year. This suggests a possible upside of 8.2% from the stock's current price.
View analysts price targets for OLK
or view top-rated stocks among Wall Street analysts.

How have OLK shares performed in 2024?

Olink Holding AB (publ)'s stock was trading at $25.15 at the beginning of 2024. Since then, OLK shares have decreased by 4.5% and is now trading at $24.03.
View the best growth stocks for 2024 here
.

When is Olink Holding AB (publ)'s next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 14th 2024.
View our OLK earnings forecast
.

How were Olink Holding AB (publ)'s earnings last quarter?

Olink Holding AB (publ) (NASDAQ:OLK) issued its earnings results on Monday, May, 13th. The company reported ($0.13) EPS for the quarter, missing the consensus estimate of ($0.12) by $0.01. The business earned $28.75 million during the quarter, compared to analysts' expectations of $31.29 million. Olink Holding AB (publ) had a negative trailing twelve-month return on equity of 7.07% and a negative net margin of 19.72%.

What ETFs hold Olink Holding AB (publ)'s stock?

ETFs with the largest weight of Olink Holding AB (publ) (NASDAQ:OLK) stock in their portfolio include AltShares Event-Driven ET (EVNT) and IQ Merger Arbitrage ETF (MNA).AltShares Merger Arbitrage ETF (ARB).

When did Olink Holding AB (publ) IPO?

Olink Holding AB (publ) (OLK) raised $301 million in an IPO on Thursday, March 25th 2021. The company issued 17,700,000 shares at $16.00-$18.00 per share. Goldman Sachs, Morgan Stanley and SVB Leerink acted as the underwriters for the IPO and BTIG was co-manager.

Who are Olink Holding AB (publ)'s major shareholders?

Olink Holding AB (publ)'s stock is owned by a number of institutional and retail investors. Top institutional shareholders include Price T Rowe Associates Inc. MD (0.70%), Absolute Gestao de Investimentos Ltda. (0.44%), Gabelli Funds LLC (0.43%), KRYGER CAPITAL Ltd (0.39%), Healthcare of Ontario Pension Plan Trust Fund (0.32%) and Principal Financial Group Inc. (0.30%).

How do I buy shares of Olink Holding AB (publ)?

Shares of OLK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:OLK) was last updated on 5/29/2024 by MarketBeat.com Staff

From Our Partners